“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about BioNTech SE
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
+10
At BioNTech we understand that every cancer patients tumor is unique and therefore each patients treatment should be individualized. To pioneer the next generation of patient-specific immunotherapies, we have combined ground-breaking research with cutting-edge technologies to develop therapeutics for cancer and beyond. Our broad and synergistic suite of platforms, which include mRNA therapeutics, engineered cell therapies, antibodies and small molecule immunomodulators have been optimized for distinct modes of action, high precision targeting, high potency and efficacy. We are also developing in parallel our own state-of-the-art manufacturing processes to complement our drug development platforms. We were founded in 2008 in Mainz, Germany and have been driven to become the leading global biotechnology company for individualized cancer medicine. We have over 20 product candidates in development, 8 candidates in 9 ongoing clinical trials, treated over 250 patients across 17 tumor t...
| C-Level 13 | VP - Level57 |
| Director993 | Manager475 |
| Others1241 | |
| Structure | Email Format |
|---|---|
| <f><last>@ |
|
| <first>@ | John@biontech.de |
| <f>.<last>@ |
|
| <first>.<last>@ | John.Smith@biontech.de |
| <l><f>@ |
|
| Pain Points | Locations | Technologies |
|---|---|---|
| Application Development | Frankfurt Rhine-Main Metropolitan Area | database, continuous improvement, testing, voice, change management, quality assurance, communication, compliance, acceptance testing, customer service, order management, basic, calibration, troubleshooting, scheduling, operations, financial, gmp, e, risk, collaboration, talent acquisition |
| Application Development | Mainz, Rhineland-Palatinate, Germany | quality assurance, uat, communication, e, testing, voice, compliance, data management, release testing, security, rfp, troubleshooting, sox, share, operations, financial, talent acquisition |
| Application Development | Marburg an der Lahn, Hesse, Germany | natural, communication, cgmp, voice, compliance, collaboration, troubleshooting |
| Application Development | Munich, Bavaria, Germany | database, data transfer, e, voice, operating procedures, collaboration, data collection, talent acquisition |
| Application Development | Shanghai, Shanghai, China | integrity, natural, collaboration, e |
BioNTech SE looking to hire in Compliance in Frankfurt Rhine-Main Metropolitan Area
BioNTech SE looking to hire in Digital Transformation in Frankfurt Rhine-Main Metropolitan Area
BioNTech SE looking to hire in ERP Implementation in Frankfurt Rhine-Main Metropolitan Area
Amazon connect
Amazon connect
Atlassian jira
Buffer
Cmms
Agile
Application lifecycle management (alm)
Ci/cd
Devops
Infrastructure management
London, United Kingdom; Cambridge, US; Mainz, Germany | full time | Job ID: 9111As Manager Clinic...
View MoreMainz, Deutschland | Vollzeit | Job ID: 9108Als Finance Business Partner R&D (m/w/d) stellst du d...
View MoreAs a Director of Clinical Data Management, you will be responsible for the effective leadership, ...
View MoreMainz, Germany | full time | Job ID: 9157Your responsibilities:You will be accountable for the en...
View MoreMainz, Deutschland | Vollzeit | Job ID: 9071Ab September 2025Dauer: 3,5 JahreDu interessierst dic...
View MoreShanghai, China | full time | Job ID: 7287Your main responsibilities are:Lead and Drive study del...
View MoreHead of Manufacturing, Science & Technology MarburgMarburg, Germany | full time | Job ID:8957Do y...
View MoreMainz, Germany; Berlin, Germany; London, United Kingdom | full time | Job ID: 8580Main Responsibi...
View More【Investor Updates】✌️ Our smart portfolio tools automatically track entry/exit signals, letting you focus on high-potential stocks — many of which have
Read MoreBMO Capital analyst Evan Seigerman has maintained their bullish stance on BNTX stock, giving a Buy rating today. Evan Seigerman has given his Buy rating due
Read MoreCureVac NV: * EQS-NEWS: CUREVAC RECEIVES ADDITIONAL POSITIVE VALIDITY DECISION FROM EUROPEAN PATENT OFFICE IN ONGOING LITIGATION AGAINST BIONTECH SE
Read MoreEuropean Patent Office largely dismisses opposition filed by BioNTech SE, Pfizer Inc., and others in December 2023 challenging validity of EP 4 023 755 B1
Read MoreAt BioNTech we understand that every cancer patients tumor is unique and therefore each patients treatment should be individualized. To pioneer the next generation of patient-specific immunotherapies, we have combined ground-breaking research with cutting-edge technologies to develop therapeutics for cancer and beyond. Our broad and synergistic suite of platforms, which include mRNA therapeutics, engineered cell therapies, antibodies and small molecule immunomodulators have been optimized for distinct modes of action, high precision targeting, high potency and efficacy. We are also developing in parallel our own state-of-the-art manufacturing processes to complement our drug development platforms. We were founded in 2008 in Mainz,...
Biotechnology,individualized cancer medicine,patient-specific immunotherapy,mrna therapeutics,cell therapy,antibody therapeutics,small molecule immunomodulators,tailored therapeutics,immunotherapy,oncology,car t,tcr,bispecific antibodies,rare diseases,and infectious diseases
Biontech se operates in the Biotechnology research industry.
Biontech se's HQ phone number is +49 6131 90840
Biontech se's revenue is $2.51b
Biontech se has 1001 - 5000 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.